The Burden of RSV and Bronchiolitis in the US Infant Medicaid Population Extends Beyond the Inpatient Setting
Sunday, April 30, 2023
3:00 PM – 3:15 PM ET
Location: Convention Center: 201
Publication Number: 2495.5
Mina Suh, EpidStrategies, Mission Viejo, CA, United States; Heidi Reichert, EpidStrategies, Ann Arbor, MI, United States; Xiaohui Jiang, Epidstrategies, Ann Arbor, MI, United States; Susan T. Pastula, ToxStrategies, Ann Arbor, MI, United States; Naimisha Movva, EpidStrategies, A Division of ToxStrategies, Rockville, MD, United States; Jon Fryzek, EpidStrategies, Rockville, MD, United States; Eric Simoes, University of Colorado School of Medicine, aurora, CO, United States
Presenting Author(s)
MS
Mina Suh, MPH
Senior Epidemiologist EpidStrategies Mission Viejo, California, United States
Disclosure(s):
Mina Suh, MPH: AstraZeneca (Terminated, August 31, 2022) (Products/Services: Contractor including contracted research); Sanofi (Ongoing) (Products/Services: Contractor including contracted research); Sobi (Terminated, June 30, 2021) (Products/Services: Contractor including contracted research)
Heidi Reichert, MA: AstraZeneca (Terminated, August 31, 2022) (Products/Services: Contractor including contracted research); Sanofi (Ongoing) (Products/Services: Contractor including contracted research)
Xiaohui Jiang, MS: AstraZeneca (Terminated, August 31, 2022) (Products/Services: Contractor including contracted research); Sanofi (Ongoing) (Products/Services: Contractor including contracted research); Sobi (Terminated, June 30, 2021) (Products/Services: Contractor including contracted research)
Susan T. Pastula, BS, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Naimisha Movva, MPH: AstraZeneca (Terminated, August 31, 2022) (Products/Services: Contractor including contracted research); Sanofi (Ongoing) (Products/Services: Contractor including contracted research)
Jon Fryzek, PhD: AstraZeneca (Terminated, August 31, 2022) (Products/Services: Contractor including contracted research); Sanofi (Ongoing) (Products/Services: Contractor including contracted research); Sobi (Terminated, June 30, 2021) (Products/Services: Contractor including contracted research)
Eric Simões, MD: Astrazeneca (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Icosavax (Ongoing) (Products/Services: Advisory Committee); Merck (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Pfizer (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)
